These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 11122977)

  • 21. Clinical features associated to refractory obsessive-compulsive disorder.
    Ferrão YA; Shavitt RG; Bedin NR; de Mathis ME; Carlos Lopes A; Fontenelle LF; Torres AR; Miguel EC
    J Affect Disord; 2006 Aug; 94(1-3):199-209. PubMed ID: 16764938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of the efficacy of trial-based cognitive therapy for obsessive-compulsive disorder: preliminary findings.
    Rodrigues EP; Fechine AJB; Oliveira AC; Matos CFF; Passarela CM; Hemanny C; Dias FM; Batista JW; Albuquerque LCN; Soares MS; Coelho PE; Araújo VPC; Ayres ZM; de Oliveira IR
    Trends Psychiatry Psychother; 2023; 45():e20210247. PubMed ID: 35500249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
    J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
    March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
    Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obsessive-compulsive disorder. Diagnosis and management.
    Ladouceur R; Freeston M; Gagnon F
    Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
    Bloch MH; Storch EA
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy for obsessive-compulsive disorder.
    Dougherty DD; Rauch SL; Jenike MA
    J Clin Psychol; 2004 Nov; 60(11):1195-202. PubMed ID: 15389617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of compulsive hoarding.
    Saxena S; Maidment KM
    J Clin Psychol; 2004 Nov; 60(11):1143-54. PubMed ID: 15389621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?
    Wheaton MG; Rosenfield D; Foa EB; Simpson HB
    J Consult Clin Psychol; 2015 Oct; 83(5):926-937. PubMed ID: 26009783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obsessive-compulsive disorder: a critical review of therapeutic perspectives.
    Schruers K; Koning K; Luermans J; Haack MJ; Griez E
    Acta Psychiatr Scand; 2005 Apr; 111(4):261-71. PubMed ID: 15740462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity.
    Brakoulias V
    Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors.
    Vythilingum B; Cartwright C; Hollander E
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S7-13. PubMed ID: 11110014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition and treatment of obsessive-compulsive disorder.
    Goodman WK; Lydiard RB
    J Clin Psychiatry; 2007 Dec; 68(12):e30. PubMed ID: 18162010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
    Besiroglu L; Çetinkaya N; Selvi Y; Atli A
    Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.
    Fineberg NA; Reghunandanan S; Simpson HB; Phillips KA; Richter MA; Matthews K; Stein DJ; Sareen J; Brown A; Sookman D;
    Psychiatry Res; 2015 May; 227(1):114-25. PubMed ID: 25681005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining Pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorder.
    Cottraux J; Bouvard MA; Milliery M
    Cogn Behav Ther; 2005; 34(3):185-92. PubMed ID: 16201063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathogenesis and treatment of obsessive-compulsive disorder.
    Dolberg OT; Iancu I; Sasson Y; Zohar J
    Clin Neuropharmacol; 1996 Apr; 19(2):129-47. PubMed ID: 8777767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
    Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
    BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.